|
2022
|
Invention
|
Use of cistanche tubulosa extract in the preparation of a medicament for relieving dry eye syndro... |
|
2018
|
Invention
|
Anti-fatigue composition for use in improving endurance performance. A composition, comprising a ... |
|
|
Invention
|
Application of poria extract and active ingredients thereof in the modification, prevention and/o... |
|
2017
|
Invention
|
Use of poria extract and active ingredient thereof in skin care and/or promoting wound healing. P... |
|
|
Invention
|
Poria cocos fermentation product and preparation method therefor. A Poria cocos fermentation prod... |
|
|
Invention
|
Poria cocos skin extract, poricoic acid a, and poricoic acid b and application thereof for blood ... |
|
|
Invention
|
Uses of poria cocos extract and tumulosic acid in protecting muscles. Uses of a poria cocos extra... |
|
|
Invention
|
Use of cistanche tubulosa extract and isoacteoside in protection of muscles. Disclosed is a use o... |
|
|
Invention
|
Uses of cistanche tubulosa extract and isoacteoside in protecting muscle. Cistanche tubulosa extr... |
|
2015
|
Invention
|
Use of cistanche tubulosa extract in the preparation of drugs or foods for protecting ocular cell... |
|
|
Invention
|
K2 composition, preparation method therefor, and application thereof. A method for providi... |
|
|
Invention
|
K2 composition, preparation method therefor, and application thereof. A method for providing pori... |
|
|
Invention
|
Isoacteoside derivative and preparation method and use thereof. An isoacteoside derivative and pr... |
|
2014
|
Invention
|
Medicament for regulating blood sugar. Disclosed is use of an active ingredient in the preparatio... |
|
2012
|
Invention
|
Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or... |
|
|
Invention
|
Medical composition for preventing or treating amyloid β peptide related diseases or conditions. ... |
|
2011
|
Invention
|
Use of isoacteoside or pharmaceutically acceptable salt thereof. Isoacteoside or a pharmace... |
|
|
Invention
|
Use of isoacteoside or pharmaceutically acceptable salt thereof. Isoacteoside or a pharmaceutical... |
|
|
Invention
|
Method for preventing or treating amyloid beta peptide-associated diseases or conditions, and met... |
|
2010
|
Invention
|
Use of lanostanes and extracts from poria cocos for treating diabetes. A pharmaceutical compositi... |
|
|
Invention
|
Poria extract in treating diabetes. Poria extract contains 1-60% of the lanostane compounds by we... |
|
|
Invention
|
Use of lanostanes and extracts from poria cocos for treating cachexia. A pharmaceutical compositi... |
|
|
Invention
|
Poria extract in treating cachexia. Poria extract contains 1-60% of the lanostane compounds by we... |
|
2009
|
Invention
|
Pharmaceutical composition for treating or preventing angina or myocardial infarction induced by ... |
|
2008
|
Invention
|
Pharmaceutical composition and extract of poria for treating a disease induced from immune disord... |
|
|
Invention
|
A pharmaceutical composition for treating disease caused by immune disturbance and the extract fr... |
|
|
Invention
|
Pharmaceutical composition and poria extract useful for enhancing absorption of nutrients. ... |
|
|
Invention
|
Pharmaceutical composition and poria extract useful for enhancing absorption of nutrients. The in... |
|
|
Invention
|
The neuroblast proliferation promoter and the neurite outgrowth promoter. A neuroblast proliferat... |
